XML 79 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The following reflects total stock-based compensation expense recognized under all programs:
Year Ended December 31,
202220212020
Related to L&W stock options$$31 $
Related to L&W RSUs56 75 26 
Related to SciPlay RSUs12 22 
   Total(1)
$69 $113 $56 
(1) The years ended December 31, 2022 and 2021 include $24 million and $34 million, respectively, classified as liability awards.
Schedule of change in the number of shares of Class A common stock
The following table sets forth the change in the number of shares of common stock outstanding during the fiscal years ended December 31, 2022 and 2021:
 December 31,
 20222021
Shares outstanding as of beginning of period97 95 
Shares issued as part of equity-based compensation plans and the employee stock purchase plan (“ESPP”), net of shares surrendered
Shares repurchased into treasury stock(7)— 
Shares outstanding as of end of period91 97 
Share-based Payment Arrangement, Option, Activity
A summary of the changes in stock options outstanding under our equity-based compensation plans during 2022 is presented below:
Number of OptionsWeighted Average Remaining Contract Term (Years)Weighted Average Exercise Price (per share)Aggregate Intrinsic Value
Options outstanding as of December 31, 2021
2.0 5.3$33.59 $68 
Granted— — $57.67 $— 
Exercised(0.1)— $25.94 $
Cancelled(0.1)— $22.69 $— 
Options outstanding as of December 31, 2022
1.8 3.5$34.40 $45 
Options exercisable as of December 31, 2022
1.8 3.5$34.35 $44 
Options expected to vest as of December 31, 2022
0.1 7.2$37.49 $
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average assumptions used in the model are outlined in the following table:
202220212020
Assumptions:
Expected volatility71 %74 %75 %
Risk-free interest rate3.01 %0.96 %0.36 %
Dividend yield— — — 
Expected life (in years)666
RSUs outstanding under equity-based compensation plans
A summary of the changes in RSUs outstanding under our equity-based compensation plans during 2022 is presented below:
Number of Restricted Stock UnitsWeighted Average Grant Date Fair Value
Unvested RSUs as of December 31, 2021
2.7 $32.03 
Granted1.8 $56.88 
Vested(2.0)$38.91 
Cancelled(0.8)$38.23 
Unvested RSUs as of December 31, 2022
1.7 $46.66